• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Cardiology

Contactless atrial fibrillation detection system achieves clinical-grade accuracy

AI, atrial fibrillation, 20 May 2025/in Cardiology, Cardiovascular Disease, E-News /by panglobal

A groundbreaking contactless detection system for atrial fibrillation using radio technology and artificial intelligence has demonstrated clinical-grade diagnostic accuracy. Published in Nature Communications, the innovative system records heart mechanical motion via radar sensing and analyses it using neural networks, enabling detection without physical contact and potentially facilitating early diagnosis before symptoms appear.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/Afib_Diagram.jpg 1326 2300 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-20 18:00:472025-05-19 09:05:36Contactless atrial fibrillation detection system achieves clinical-grade accuracy
Edwards Lifesciences obtains CE Mark for SAPIEN M3

Edwards receives CE mark for transfemoral mitral valve replacement system

, 17 April 2025/in Cardiology, Product News /by panglobal

Edwards Lifesciences has obtained European regulatory approval for its SAPIEN M3 system, making it the world’s first transcatheter mitral valve replacement therapy delivered via a transfemoral approach for treating mitral regurgitation.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Sapien_M3-scaled.jpg 1440 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-17 08:00:522025-04-16 09:53:54Edwards receives CE mark for transfemoral mitral valve replacement system

Clinical trial validates bioengineered blood vessels for trauma surgery

, 23 January 2025/in Cardiology, E-News, Surgery, Wound Care /by panglobal

Phase II trial demonstrates superior outcomes compared to synthetic grafts in both civilian and military settings, with significantly lower amputation rates and infection risks.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/01/blood.jpg 480 640 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-01-23 08:00:262025-01-22 12:09:40Clinical trial validates bioengineered blood vessels for trauma surgery

SGLT2 inhibitors emerge as key players in cardiac protection research

heart attack, 21 December 2024/in Cardiology, E-News, Research /by panglobal

A European research initiative has made significant progress in identifying new treatments to protect heart muscle during acute cardiac events, with potential implications for both diabetic and non-diabetic patients.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/12/Europe_heart.png 506 900 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-12-21 08:06:362024-12-21 08:06:36SGLT2 inhibitors emerge as key players in cardiac protection research
Dr. Feras Khaliel

The world’s first fully robotic heart transplant: We interview the cardiac surgeon about the procedure

heart transplant, KFSHRC, Robotics, world-first, 8 October 2024/in Cardiology, Featured Articles, MedTech, Surgery /by panglobal

In an historic achievement, Dr. Feras Khaliel and his team at King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh, Saudi Arabia, successfully performed the world’s first fully robotic heart transplant on a 16-year-old patient with end-stage heart failure. This innovative procedure reduced recovery times and surgical risks, setting a new standard for cardiac […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/Dr-Feras-Khaliel_1.jpg 1009 2000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-08 11:27:402024-10-08 11:27:40The world’s first fully robotic heart transplant: We interview the cardiac surgeon about the procedure
Johan Frostegård

New cardiovascular risk marker identified in older women

biomarker, heart disease, Karolinska Institutet, women, 3 October 2024/in Cardiology, E-News, Women's Health /by panglobal

A study from Karolinska Institutet reveals that low levels of anti-phosphorylcholine antibodies may indicate increased risk of heart disease in older women, potentially paving the way for improved risk assessment and preventive strategies.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/Johan-Frostegard.jpg 522 359 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-03 08:00:092024-10-02 11:02:35New cardiovascular risk marker identified in older women
surgeons at work

New guideline for cardiovascular management in noncardiac surgery released

cardiovascular risk, Circulation, guideline, JACC, Surgery, 27 September 2024/in Cardiology, E-News, Surgery /by panglobal

The American Heart Association and American College of Cardiology have jointly published an updated guideline for managing cardiovascular risks in patients undergoing noncardiac surgery, reflecting a decade of new evidence since the last update in 2014.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/surgeons_at_work.jpg 679 1018 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-27 08:06:092024-09-27 08:06:09New guideline for cardiovascular management in noncardiac surgery released
quit smoking

ESC Congress 2024: Quitting smoking halves cardiovascular risk in coronary artery disease patients

cardiovascular disease, ESC, Research, smoking, 2 September 2024/in Cardiology, Cardiovascular Disease, E-News /by panglobal

New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/smoking.jpg 584 876 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-02 10:53:292024-09-02 10:53:29ESC Congress 2024: Quitting smoking halves cardiovascular risk in coronary artery disease patients
Professor Maciej Banach of the Medical University of Lodz

ESC Congress 2024: Experts call for routine screening of Lipoprotein(a) in cardiovascular health

cardiovascular disease, ESC, Europe, lipoprotein(a), screening, 2 September 2024/in Cardiology, Cardiovascular Disease, E-News /by panglobal

A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/Maciej_Banach.jpg 1274 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-02 10:48:022024-09-02 10:48:02ESC Congress 2024: Experts call for routine screening of Lipoprotein(a) in cardiovascular health
BiVACOR Total Artificial HeartBiVACOR

BiVACOR Total Artificial Heart: First-in-human implantation marks new era in cardiac care

Artificial Heart, BiVACOR, bridge-to-transplant, Texas Heart Institute, 25 July 2024/in Cardiology, E-News, Editors' Picks, MedTech /by panglobal

A groundbreaking titanium artificial heart with a single moving part has been successfully implanted in a patient with end-stage heart failure, potentially revolutionising treatment options for those awaiting transplantation.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/BiVACOR-Total-Artificial-Heart.jpg 1055 2000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-25 13:50:362024-07-25 13:50:36BiVACOR Total Artificial Heart: First-in-human implantation marks new era in cardiac care
Page 1 of 212

Latest issue of International Hospital

April 2024

28 May 2025

Breakthrough in vivo gene therapy targets newborn blood stem cells

28 May 2025

Major study exposes social media’s toxic impact on child mental health

27 May 2025

Ransomware emerges as primary driver of healthcare data breaches

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription